Copyright
©The Author(s) 2016.
World J Diabetes. Sep 15, 2016; 7(17): 354-395
Published online Sep 15, 2016. doi: 10.4239/wjd.v7.i17.354
Published online Sep 15, 2016. doi: 10.4239/wjd.v7.i17.354
Table 5 Type of insulin by onset of action, peak effect and duration of action
Insulin type | Onset of action | Peak effect | Duration of action |
Lispro, aspart, glulisine | 5 to 15 min | 45 to 75 min | 2 to 4 h |
Regular | About 30 min | 2 to 4 h | 5 to 8 h |
NPH | About 2 h | 4 to 12 h | 18 to 28 h |
Insulin glargine | About 2 h | No peak | 20 to 24 h |
Insulin detemir | About 2 h | No peak | 6 to 24 h1 |
NPL | About 2 h | Six hours | 15 h |
Insulin degludec | About 2 h | No peak | > 40 h |
Insulin U-300 | About 2 h | No peak | > 36 h |
- Citation: Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes 2016; 7(17): 354-395
- URL: https://www.wjgnet.com/1948-9358/full/v7/i17/354.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i17.354